217 related articles for article (PubMed ID: 35748254)
1. COVID-19 Lockdown Impacts Among Patients with Cystic Fibrosis: An Italian Regional Reference Centre Experience.
Boni A; Murciano M; De Luca F; Rizzo V; Cappelli C; D'Alù V; Troiani P; Nenna R; Cimino G; Midulla F
Front Biosci (Landmark Ed); 2022 Jun; 27(6):178. PubMed ID: 35748254
[TBL] [Abstract][Full Text] [Related]
2. [Italian Cystic Fibrosis Registry (ICFR). Report 2021-2022].
Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2024; 48(2 Suppl 2):1-41. PubMed ID: 38742380
[TBL] [Abstract][Full Text] [Related]
3. [Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2021; 45(3 Suppl 1):1-37. PubMed ID: 34132083
[TBL] [Abstract][Full Text] [Related]
4. [Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].
Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2019; 43(4S1):1-36. PubMed ID: 31370382
[TBL] [Abstract][Full Text] [Related]
5. [Italian Cystic Fibrosis Registry (ICFR). Report 2019-2020].
Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2022; 46(4 Suppl 2):1-38. PubMed ID: 36102313
[TBL] [Abstract][Full Text] [Related]
6. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
7. [Italian Cystic Fibrosis Register - Report 2010].
Amato A; Ferrigno L; Salvatore M; Toccaceli V;
Epidemiol Prev; 2016; 40(2 Suppl 2):1-47. PubMed ID: 27291389
[TBL] [Abstract][Full Text] [Related]
8. [Italian Cystic Fibrosis Registry. Report 2011-2014].
Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2018; 42(1S1):1-32. PubMed ID: 29506377
[TBL] [Abstract][Full Text] [Related]
9. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
Lee TW; Southern KW; Perry LA; Penny-Dimri JC; Aslam AA
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005599. PubMed ID: 27314455
[TBL] [Abstract][Full Text] [Related]
10. Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN).
Oubaya N; Pombet T; Delestrain C; Remus N; Douvry B; Grenet D; Corvol H; Thouvenin G; Prulière-Escabasse V; Mounir H; Argoud D; Fretigne C; Costes L; Mackiewicz MP; Jung C; Ahamada L; Lanone S; Maitre B; Bégot AC; Epaud R
Front Public Health; 2022; 10():978627. PubMed ID: 36452951
[TBL] [Abstract][Full Text] [Related]
11. Recommended shielding against COVID-19 impacts physical activity levels in adults with cystic fibrosis.
Radtke T; Haile SR; Dressel H; Benden C
J Cyst Fibros; 2020 Nov; 19(6):875-879. PubMed ID: 32878732
[TBL] [Abstract][Full Text] [Related]
12. Change in CF care during COVID-19 pandemic: Single-center experience in a middle-income setting.
Hatziagorou E; Toulia I; Avramidou V; Kampouras A; Tsara V; Tsanakas J
Pediatr Pulmonol; 2021 Sep; 56(9):3065-3067. PubMed ID: 34265187
[TBL] [Abstract][Full Text] [Related]
13. Impact of COVID-19 social distancing recommendations on pulmonary function, nutritional status, and morbidity in patients with cystic fibrosis.
Bagatini MA; Heinzmann-Filho JP; Vendrusculo FM; Pinto LA; Donadio MVF
Rev Paul Pediatr; 2023; 42():e2022198. PubMed ID: 37646749
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
[TBL] [Abstract][Full Text] [Related]
15. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
16. Airway clearance devices for cystic fibrosis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(26):1-50. PubMed ID: 23074531
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of nutritional status with clinical characteristics and lung function in children with cystic fibrosis].
Li DD; Shen YL; Wang MC; Yang WL; Xia LL; Zhang YQ; Zhao SY; Yan J
Zhongguo Dang Dai Er Ke Za Zhi; 2024 Mar; 26(3):275-281. PubMed ID: 38557380
[TBL] [Abstract][Full Text] [Related]
18. Changes in Care during the COVID-19 Pandemic for People with Cystic Fibrosis.
Sanders DB; Wu R; O'Neil T; Elbert A; Petren K; Jain R; Ren CL
Ann Am Thorac Soc; 2022 Oct; 19(10):1697-1703. PubMed ID: 35143374
[No Abstract] [Full Text] [Related]
19. Body Weight and Body Mass Index in Patients with End-Stage Cystic Fibrosis Stabilize After the Start of Enteral Tube Feeding.
Hollander FM; de Roos NM; Belle van Meerkerk G; Teding van Berkhout F; Heijerman HGM; van de Graaf EA
J Acad Nutr Diet; 2017 Nov; 117(11):1808-1815. PubMed ID: 28919081
[TBL] [Abstract][Full Text] [Related]
20. Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.
Keller BM; Aebischer CC; Kraemer R; Schöni MH
J Cyst Fibros; 2003 Jun; 2(2):76-83. PubMed ID: 15463854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
